Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

During the Trading Day
210.34 -4.28 / -1.99%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
209.90 -4.72 / -2.20%
 
Volume: --

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Operating ActivitiesNet Income / Starting Line-512.3M-241.6M5.3B-629.3M
 
 
 
 
 
Depreciation982.6M1.7B1.2B1.6B
 
 
 
 
 
Total Other Cash Flow781.0M961.8M1.2B696.5M
 
 
 
 
 
Funds From Operations947.0M2.2B896.1M1.8B
 
 
 
 
 
Funds From/For Other Operating Expenses422.0M783.1M-152.1M219.2M
 
 
 
 
 
Net Cash Flow - Operating Activities525.0M1.4B1.0B1.6B
 
 
 
 
 
 
InvestingIncrease In Investments-15.0M-6.0M-6.0M2.7M
 
 
 
 
 
Decrease In Investments----0.00883.0M
 
 
Capital Expenditures-136.6M-111.6M-102.5M-104.2M
 
 
 
 
 
Fixed Asset Disposal74.9M6.6M52.1M6.5M
 
 
 
 
 
Net Assets From Acquisitions -34.6B-463.7M-132.8M-2.3B
 
 
 
 
 
Other Investing - Sources790.5M65.3M0.00--
 
 
 
Net Cash Flow Investing-33.9B-529.4M-251.8M-2.4B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings29.0B72.8M0.00799.3M
 
 
 
 
Long Term Debt Reduction-2.7B-1.4B-230.5M-807.5M
 
 
 
 
 
Net Proceeds Stock Sale9.0B65.6M87.6M34.2M
 
 
 
 
 
Common Preferred Redeemed-64.1M-36.9M-7.2M-9.8M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.00-68.7M-69.7M-69.7M
 
 
 
 
Other Sources - Financing36.1M200.0K17.7M22.1M
 
 
 
 
 
Other Uses - Financing24.6M67.4M46.3M91.8M
 
 
 
 
 
Net Cash Flow - Financing35.3B-1.5B-248.4M-123.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.8M1.7M-2.0M-1.4M
 
 
 
 
 
 
Net Change In Cash1.9B-598.7M548.0M-966.5M